| Product Code: ETC11813743 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to import carfilzomib mainly from Switzerland, UK, Belgium, USA, and Germany. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low, indicating a diverse import market. Despite a slight decline in the compound annual growth rate (CAGR) from 2020-2024 at -2.14%, the overall growth rate from 2023-2024 showed a marginal improvement at -0.41%. This data suggests a stable and competitive landscape for carfilzomib imports in Israel, with multiple countries contributing to supply.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Carfilzomib Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Carfilzomib Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Carfilzomib Market - Industry Life Cycle |
3.4 Israel Carfilzomib Market - Porter's Five Forces |
3.5 Israel Carfilzomib Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 Israel Carfilzomib Market Revenues & Volume Share, By Technology Type, 2022 & 2032F |
3.7 Israel Carfilzomib Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.8 Israel Carfilzomib Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Israel Carfilzomib Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Carfilzomib Market Trends |
6 Israel Carfilzomib Market, By Types |
6.1 Israel Carfilzomib Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Carfilzomib Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 Israel Carfilzomib Market Revenues & Volume, By Carfilzomib Injection, 2022 - 2032F |
6.1.4 Israel Carfilzomib Market Revenues & Volume, By Generic Carfilzomib, 2022 - 2032F |
6.1.5 Israel Carfilzomib Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.1.6 Israel Carfilzomib Market Revenues & Volume, By Research Use Drugs, 2022 - 2032F |
6.2 Israel Carfilzomib Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Carfilzomib Market Revenues & Volume, By Targeted Therapy, 2022 - 2032F |
6.2.3 Israel Carfilzomib Market Revenues & Volume, By Small Molecule Drugs, 2022 - 2032F |
6.2.4 Israel Carfilzomib Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.2.5 Israel Carfilzomib Market Revenues & Volume, By Bioinformatics Analysis, 2022 - 2032F |
6.3 Israel Carfilzomib Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Carfilzomib Market Revenues & Volume, By Cancer Patients, 2022 - 2032F |
6.3.3 Israel Carfilzomib Market Revenues & Volume, By Healthcare Providers, 2022 - 2032F |
6.3.4 Israel Carfilzomib Market Revenues & Volume, By Oncology Centers, 2022 - 2032F |
6.3.5 Israel Carfilzomib Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4 Israel Carfilzomib Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Israel Carfilzomib Market Revenues & Volume, By Multiple Myeloma Treatment, 2022 - 2032F |
6.4.3 Israel Carfilzomib Market Revenues & Volume, By Cost-effective Cancer Treatment, 2022 - 2032F |
6.4.4 Israel Carfilzomib Market Revenues & Volume, By Enhanced Treatment Effectiveness, 2022 - 2032F |
6.4.5 Israel Carfilzomib Market Revenues & Volume, By Cancer Drug Development, 2022 - 2032F |
7 Israel Carfilzomib Market Import-Export Trade Statistics |
7.1 Israel Carfilzomib Market Export to Major Countries |
7.2 Israel Carfilzomib Market Imports from Major Countries |
8 Israel Carfilzomib Market Key Performance Indicators |
9 Israel Carfilzomib Market - Opportunity Assessment |
9.1 Israel Carfilzomib Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 Israel Carfilzomib Market Opportunity Assessment, By Technology Type, 2022 & 2032F |
9.3 Israel Carfilzomib Market Opportunity Assessment, By End User, 2022 & 2032F |
9.4 Israel Carfilzomib Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Israel Carfilzomib Market - Competitive Landscape |
10.1 Israel Carfilzomib Market Revenue Share, By Companies, 2025 |
10.2 Israel Carfilzomib Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here